Authors:
CURET O
DAMOISEAU G
AUBIN N
SONTAG N
ROVEI V
JARREAU FX
Citation: O. Curet et al., BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE OXIDASE-A INHIBITOR .1. BIOCHEMICAL PROFILE, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 253-264
Authors:
CAILLE D
BERGIS OE
FANKHAUSER C
GARDES A
ADAM R
CHARIERAS T
GROSSET A
ROVEI V
JARREAU FX
Citation: D. Caille et al., BEFLOXATONE, A NEW REVERSIBLE AND SELECTIVE MONOAMINE OXIDASE-A INHIBITOR .2. PHARMACOLOGICAL PROFILE, The Journal of pharmacology and experimental therapeutics, 277(1), 1996, pp. 265-277
Authors:
MOUREAU F
WOUTERS J
DEPAS M
VERCAUTEREN DP
DURANT F
DUCREY F
KOENIG JJ
JARREAU FX
Citation: F. Moureau et al., A REVERSIBLE MONOAMINE-OXIDASE INHIBITOR TOLOXATONE - COMPARISON OF ITS PHYSICOCHEMICAL PROPERTIES WITH THOSE OF OTHER INHIBITORS INCLUDINGBROFAROMINE, HARMINE, R40519 AND MOCLOBEMIDE, European journal of medicinal chemistry, 30(11), 1995, pp. 823-838
Authors:
WOUTERS J
MOUREAU F
VERCAUTEREN DP
EVRARD G
DURANT F
KOENIG JJ
DUCREY F
JARREAU FX
Citation: J. Wouters et al., EXPERIMENTAL AND THEORETICAL-STUDY OF REVERSIBLE MONOAMINE-OXIDASE INHIBITORS - STRUCTURAL APPROACH OF THE ACTIVE-SITE OF THE ENZYME, Journal of neural transmission. Supplementum, (41), 1994, pp. 313-319
Authors:
ROVEI V
CAILLE D
CURET O
EGO D
JARREAU FX
Citation: V. Rovei et al., BIOCHEMICAL PHARMACOLOGY OF BEFLOXATONE (MD370503), A NEW POTENT REVERSIBLE MAO-A INHIBITOR, Journal of neural transmission. Supplementum, (41), 1994, pp. 339-347
Authors:
CURET O
DAMOISEAU G
LABAUNE JP
ROVEL V
JARREAU FX
Citation: O. Curet et al., EFFECTS OF BEFLOXATONE, A NEW POTENT REVERSIBLE MAO-A INHIBITOR, ON CORTEX AND STRIATUM MONOAMINES IN FREELY MOVING RATS, Journal of neural transmission. Supplementum, (41), 1994, pp. 349-355
Authors:
MOUREAU F
WOUTERS J
VERCAUTEREN DP
COLLIN S
EVRARD G
DURANT F
DUCREY F
KOENIG JJ
JARREAU FX
Citation: F. Moureau et al., A REVERSIBLE MONOAMINE-OXIDASE INHIBITOR, TOLOXATONE - SPECTROPHOTOMETRIC AND MOLECULAR-ORBITAL STUDIES OF THE INTERACTION WITH FLAVIN ADENINE-DINUCLEOTIDE (FAD), European journal of medicinal chemistry, 29(4), 1994, pp. 269-277